New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by

Boston Scientific acquires Pfizer's Schneider for $2.1bn
09 Nov 2001
Executive Summary
Consistent with the company's plan to restructure its Medical Technology Group, Pfizer has divested its interventional cardiology division Schneider, to Boston Scientific, for $2.1bn in cash.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com